Insider Buying: Surrozen (NASDAQ:SRZN) Major Shareholder Buys $353,819.20 in Stock

Surrozen, Inc. (NASDAQ:SRZN) major shareholder Group Gp Lp Column III bought 18,052 shares of the firm’s stock in a transaction on Tuesday, January 20th. The shares were purchased at an average price of $19.60 per share, for a total transaction of $353,819.20. Following the purchase, the insider owned 1,016,658 shares in the company, valued at $19,926,496.80. This trade represents a 1.81% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Group Gp Lp Column III also recently made the following trade(s):

• On Friday, January 16th, Group Gp Lp Column III purchased 2,562 shares of Surrozen stock. The stock was purchased at an average price of $20.00 per share, with a total value of $51,240.00.
• On Thursday, January 15th, Group Gp Lp Column III acquired 11,893 shares of Surrozen stock. The stock was purchased at an average cost of $19.89 per share, with a total value of $236,551.77.
• On Wednesday, January 14th, Group Gp Lp Column III acquired 5,523 shares of Surrozen stock. The shares were purchased at an average price of $19.99 per share, for a total transaction of $110,404.77.
• On Tuesday, January 13th, Group Gp Lp Column III bought 12,470 shares of Surrozen stock. The stock was purchased at an average cost of $19.80 per share, with a total value of $246,906.00.
• On Tuesday, January 6th, Group Gp Lp Column III purchased 15,100 shares of Surrozen stock. The stock was acquired at an average price of $19.89 per share, with a total value of $300,339.00.
• On Friday, December 5th, Group Gp Lp Column III purchased 30,884 shares of Surrozen stock. The shares were acquired at an average cost of $19.54 per share, for a total transaction of $603,473.36.
• On Thursday, December 4th, Group Gp Lp Column III acquired 5,266 shares of Surrozen stock. The stock was acquired at an average price of $17.35 per share, for a total transaction of $91,365.10.
• On Thursday, November 13th, Group Gp Lp Column III bought 315,457 shares of Surrozen stock. The shares were acquired at an average price of $12.65 per share, with a total value of $3,990,531.05.

Surrozen Trading Up 4.3%

Shares of SRZN opened at $20.00 on Friday. The business’s 50 day moving average is $19.26 and its 200 day moving average is $14.21. Surrozen, Inc. has a 12-month low of $5.90 and a 12-month high of $24.94. The company has a market capitalization of $171.40 million, a PE ratio of -0.90 and a beta of 0.58.

Surrozen (NASDAQ:SRZN) last announced its quarterly earnings data on Friday, November 7th. The company reported ($3.61) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.17) by ($2.44). The company had revenue of $0.98 million for the quarter. Surrozen had a negative net margin of 2,909.10% and a negative return on equity of 4,055.04%. Equities research analysts predict that Surrozen, Inc. will post -8.49 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on SRZN shares. Lifesci Capital upgraded shares of Surrozen to a “strong-buy” rating in a research note on Thursday, November 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Surrozen in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised Surrozen to a “sell” rating in a research note on Friday, November 28th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Surrozen presently has an average rating of “Moderate Buy” and an average price target of $32.00.

Institutional Trading of Surrozen

Large investors have recently made changes to their positions in the business. Citadel Advisors LLC raised its position in shares of Surrozen by 32.8% during the 3rd quarter. Citadel Advisors LLC now owns 13,875 shares of the company’s stock valued at $179,000 after buying an additional 3,424 shares in the last quarter. Geode Capital Management LLC increased its stake in Surrozen by 22.6% during the second quarter. Geode Capital Management LLC now owns 30,963 shares of the company’s stock worth $277,000 after acquiring an additional 5,702 shares during the last quarter. Armistice Capital LLC purchased a new stake in Surrozen during the second quarter valued at approximately $536,000. Woodline Partners LP bought a new stake in shares of Surrozen in the 3rd quarter valued at approximately $621,000. Finally, Schonfeld Strategic Advisors LLC bought a new stake in shares of Surrozen in the 3rd quarter valued at approximately $889,000. 66.57% of the stock is currently owned by institutional investors.

About Surrozen

Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.

The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.